Overall Technical outlook

Price Summary

Aurobindo Pharma Limited's stock slumped -3.01% today, reflecting an lousynding market day.
Aurobindo Pharma Limited's stock opened at 1257.9 on 2025-04-25, surged to 1268.9, hit a low of 1210.0, and closed up -3.01% at 1220.1, with 779791 shares traded.
During the past 52 weeks, the highest stock price was 1569.4, and the lowest was 1051.75.
According to 28 analysts, the price of AUROPHARMA in the future is projected to be between 1140.0 and 1930.0, with an average expected price of 1470.8214.

Technicals

Support and Resistance: The current price is 1220.1, with support at 1156.15 and resistance at 1223.4. This range suggests that the price might move between these levels, with 1156.15 offering support and 1223.4 capping further gains for Aurobindo Pharma Limited.
AUROPHARMA supportResistance d4ef0d
Support/Resistance for AUROPHARMA


Aroon: The current state of the AROON is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
AUROPHARMA aroon d4ef0d
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
AUROPHARMA bbands d4ef0d
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR for AUROPHARMA continues to signal a bullish outlook, establishing a crucial support level that may help sustain the current upward momentum. This level of support suggests that the market is likely to continue trending higher, providing a foundation for ongoing bullish movement.
AUROPHARMA psar d4ef0d
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The stochastic indicator shows a bullish signal, with the K-line exceeding both the D-line and the 80 mark. This setup suggests strong upward momentum, implying that the market may continue to rise. Investors could consider this a favorable sign for continued market growth for Aurobindo Pharma Limited.
AUROPHARMA stoch d4ef0d
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
AUROPHARMA trippleSMA d4ef0d
Tripple SMA chart for Aurobindo Pharma Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.